$599

Arrowhead Reports Positive Ph3 Plozasiran Data; Avaí Partners for Insulin-Producing Cells; Novo Posts AMAZE 9 Zenagamtide Study; MiniMed Flex System Covered by Medicare

A series of cardiometabolic-related news items has been observed from Arrowhead Pharmaceuticals, Avaí Bio, Novo Nordisk, and MiniMed. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here